SLC1A5, unrelated to prognosis, was associated with CD8+ T-cell exclusion in the tumor microenvironment of squamous cell carcinoma
SLC1A5, short for solute carrier family 1 member 5, is a neutral amino acid transporter whose expression has been reported to be upregulated in various cancers, including esophageal squamous cell carcinoma (ESCC). Despite this, little has been described regarding the immunological involvement of SLC...
Main Authors: | Shutao Zheng, Tao Liu, Lu Li, Qing Liu, Conggai Huang, Yan Liang, Yiyi Tan, Li Zhang, Xiaomei Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-03-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023017784 |
Similar Items
-
Revisiting the Old Data of Heat Shock Protein 27 Expression in Squamous Cell Carcinoma: Enigmatic HSP27, More Than Heat Shock
by: Shutao Zheng, et al.
Published: (2022-05-01) -
Multiomics data analyses to identify SLC25A17 as a novel biomarker to predict the prognosis and immune microenvironment in head and neck squamous cell carcinoma
by: Yunbin Shi, et al.
Published: (2023-06-01) -
Massive Squamous Cell Carcinoma of the Orbit: A Rare Case Report
by: Smriti Nagpal Gupta, et al.
Published: (2017-11-01) -
Primary squamous cell carcinoma of the rectum: a case report and literature review
by: Neil Vyas, et al.
Published: (2016-07-01) -
Immunotherapy for the Treatment of Squamous Cell Carcinoma: Potential Benefits and Challenges
by: Tuba M. Ansary, et al.
Published: (2022-08-01)